David Zacut, MD
Chairman of the Board and acting CEO
Dr. Zacut has served as Brainsway's Chairman of the Board of Directors since the company's inception, and has been providing consulting services to Brain Research Services since May 2001. Since 1983, Dr. Zacut has been working as a senior practicing physician at Hadassah Hospital, and from 1994 through 2003, he served as a managing director of several large medical centers. In addition, Dr. Zacut serves as a director of several private companies, including Brain Research Services. Dr. Zacut holds an M.D. degree from the Hebrew University of Jerusalem.
Chief Financial Officer
Mr. Levy has over 15 years of experience in finance and administration. Prior to joining Brainsway, Mr. Levy served as Finance manager in the Latin America Division at Amdocs Ltd., responsible for accounting, financial reporting, treasury, portfolio management and finance support to Mergers & Acquisitions. Prior to Amdocs, Hadar Levy served as Chief Financial Officer & Business Development of Notal Vision, a healthcare company that researches and develops medical technologies for detecting retinal malfunction and deterioration, where he was responsible for all financial functions, and lead financial rounds of equity including M&A activities with strategic partners. Prior to this position, he served as Controller of GE Healthcare Israel. Mr. Levy began his career at Deloitte LLP, holds a BA in Accounting and Economics and an LLM degree from Bar Ilan University and is a Certified Public Accountant.
VP Sales Operations, North America
Joseph Perekupka is an award–winning sales and operations executive who designs and implements highly successful strategies and teams that drive revenue and improve market share within medical device and pharmaceutical sectors. Throughout his 20-year career, Mr. Perekupka held leadership positions in variety of companies, including Biotronik Inc., a company specializing in advanced cardiology devices, St. Jude Medical Inc., a cardiovascular manufacturing company, and Forest Laboratories, a company focusing on Manufacturing of Pharmaceutical products. In addition, he held management positions at Bristol-Meyers Squibb, Co. Mr. Perekupka earned a BA in Marketing from Pennsylvania State University and an MBA in Management and Finance from The Gabelli School of Business at Fordham University.
Mr. Segal has more than 20 years of top leadership roles in various fields including vast hi-tech management experience in a wide range of leading technological groups. In 2004 he co-founded WiTech Communications Ltd., a company providing wireless video solutions for diverse commercial applications, where he served as a Vice President. Prior to this, Ronen served as projects leader for OpTun Inc., where he was responsible for the development of sophisticated fiber-optics communications active switching components. From 1998 to 2000, he worked for the Israeli Navy's development center on a state-of-the-art submarine data communication system. From 1994 to 1998, Mr. Segal served in the Israeli Ministry of Defense’s Advanced Technology Unit. He studied at the Jerusalem College of Technology as part of a special academic reserves project in electro-optical Engineering and applied physics.
Chief Medical Officer
Dr. Tendler brings years of experience in the treatment of mental disorders as a psychiatrist. Dr. Tendler graduated in 2002 from State University of New York Downstate Medical School in Brooklyn with Distinction in Research. From 2002-2004, he trained at Tulane University in Internal Medicine and Psychiatry followed by two years at the University of Chicago in General Psychiatry, where he was chief resident of the consultation liaison service and course director for psychosomatic medicine. Dr. Tendler is Board Certified in General Psychiatry, Sleep Medicine and Behavioral Sleep Medicine . In 2006, Dr. Tendler established Advanced Mental Health Care Inc. in Florida, which has since served over 4000 patients in Palm Beach County, Florida. Dr. Tendler began using TMS clinically in 2009 for a variety of psychiatric and neurological conditions, and his clinical research sites participated in the clinical trial that led to Brainsway's FDA clearance. Currently, he has three clinical research sites studying the efficacy of Deep TMS for Bipolar Depression, Smoking Cessation, PTSD and OCD.
Yiftach Roth, Ph.D
As one of Brainsway's founders, Yiftach Roth has served as the company's Research and Development Manager since May 2006, and as a member of the company's Board of Directors since November 2006. From 2003 through 2006, Dr. Roth worked in the Advanced Technology Center of the Chaim Sheba Medical Center at Tel Hashomer as a researcher in the field of Magnetic Resonance Imaging (MRI). Dr. Roth's primary research interests are TMS and Magnetic Resonance Imaging (MRI), and he was one of the two key inventors of Brainsway's patented Deep TMS coil. Dr. Roth holds B.Sc. and M.Sc. degrees in Physics and a Ph.D. in Medical Physics from Tel Aviv University.
VP Field and Clinical Operations
Amit Ginou manages the Field and Clinical Operations at Brainsway. Prior to this, Amit served as the Clinical Trials Manager at Brainsway, conducting dozens of clinical trials at different phases to explore the efficacy and safety of Brainsway Deep TMS for diverse clinical indications. Amit holds a B.Sc. degree in Neuroscience from Bar-Ilan University, and an MA Law degree from Bar-Ilan University.
* Brainsway and the Brainsway logo are trademarks of Brainsway Ltd.